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Viral infection of the central nervous system (CNS) poses unique
challenges to the immune system with regards to controlling and
eliminating the invading pathogen. These obstacles include the
presence of a blood–brain barrier (BBB) that provides a physical
and physiological barrier that is difficult for cells and molecules to
cross, the absence of classic lymphatic drainage that may impair
the generation of an adaptive immune response, and limited MHC
class I or II expression on resident cells of the CNS, even during
periods of neuroinflammation. In addition, the CNS is composed
of a variety of highly specialized cells, many of which have limited
renewal capacity, that represent potential targets of infection by
numerous different viruses. Nonetheless, antigen-specific lympho-
cytes are ultimately able to accumulate within the CNS and
contribute to defense by reducing or eliminating the invading viral
pathogen. Alternatively, infiltration of activated cells of the
immune system may be detrimental, as these cells can contribute
to neuropathology that may result in long-term cellular damage or
death. Understanding the mechanisms that govern leukocyte
trafficking from the microvasculature into the CNS parenchyma is
therefore critical for comprehending the molecular and cellular
events that control neuroinflammation following infection by
neurotropic viruses. Chemokines, small (8–10 kDa) proteins
expressed by almost all nucleated cell types, are divided into four
subfamilies based upon the number and spacing of conserved
cysteine residues present within the amino terminus of the protein.
Chemokine function is controlled through often promiscuous
signaling via seven transmembrane G-protein-coupled receptors.
While initially characterized as important in inflammation by
targeting distinct leukocyte populations, chemokines are now
considered critical mediators of a variety of biological processes,
including development, tissue homeostasis, and coordinated
immune responses during viral infection.
Resident Cells of the CNS Secrete Chemokines in
Response to Viral Infection
Chemokines are now recognized as critical regulators of
leukocyte trafficking into the CNS. This leads to the inevitable
questions, which cells are producing chemokines and how is this
controlled? Numerous studies have revealed that resident cell
populations of the CNS are able to synthesize and secrete a variety
of chemokines. Astrocytes and microglia are the primary source of
chemokines following infection with a wide range of neurotropic
viruses, including the JHM strain of mouse hepatitis virus (JHMV),
lymphocytic choriomeningitis virus (LCMV), Theiler’s murine
encephalitis virus (TMEV), herpes simplex virus 1 (HSV1), and
human immunodeficiency virus (HIV) [1–4]. Neurons are also
capable of secreting chemokines during HIV and West Nile virus
(WNV) infection [5,6], while endothelial cells express chemokines
during simian immunodeficiency virus-induced encephalitis [7].
Both in vitro and in vivo studies have highlighted that CNS viral
infection often results in distinct chemokine signature patterns. For
example, Prehaud and colleagues have demonstrated that in vitro
infection of neurons with rabies virus (RABV) results in robust
production of chemokines, whereas HSV-1-infected neurons do
not [8]. However, specific chemokines, e.g., CXCL10 and CCL5,
are often expressed independently of either cellular tropism or
viral genetics, suggesting that factor(s) either secreted in response
to infection (such as type I interferon [IFN]) or utilized for viral
recognition are shared between many neurotropic viruses. Toll-
like receptors (TLRs) recognize both DNA and RNA and they are
able to rapidly respond to viral infection, in part, by promoting
chemokine gene expression. During TMEV infection, TLR2 and
TLR3 cooperation leads to the expression of the macrophage
chemoattractants CCL2 and CCL5 [3], while TLR2 and TLR9
mediate chemokine expression during HSV-1 infection [4,9].
Type I IFNs regulate glial-derived chemokine expression in
response to CNS infection with LCMV (Traub strain) and HSV-
1 [2,9]; however, this pathway is dispensable for expression of
other chemokines, e.g., CCL2 following infection with JMHV
[10]. Rather, JHMV viral proteins influence chemokine secretion
through as yet undefined mechanisms [11], while the HIV-1
protein Nef influences neuronal chemokine secretion [5]. More-
over, WNV-infected cerebellar granule cell neurons readily secrete
CXCL10 in vitro, while CXCL10 expression by WNV-infected
cortical neurons is muted [12]. The consequence of this differential
expression of CXCL10 is reflected in altered migration of defined
inflammatory cells into the cerebellum at the expense of other
WNV-infected CNS regions [12]. Collectively, these data illustrate
that viral infection of the CNS by a wide variety of neurotropic
viruses induces highly orchestrated and individual patterns of
chemokine secretion by resident cells of the CNS, evoked by
disparate pathways that converge into often overlapping profiles of
inflammatory cell infiltration.
Chemokines Regulate Immune Cell Access into
the CNS
Signaling events that occur early following viral infection are
often critical in dictating outcome. Recent studies have highlighted
the importance of innate immune cells in contributing to a
Citation: Hosking MP, Lane TE (2010) The Role of Chemokines during Viral
Infection of the CNS. PLoS Pathog 6(7): e1000937. doi:10.1371/journal.ppat.
1000937
Editor: Hiten D. Madhani, University of California San Francisco, United States of
America
Published July 29, 2010
Copyright:  2010 Hosking, Lane. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This work was funded by National Institutes of Health grant NS41249
to TEL. MPH was supported by NIH T32 AI-060573. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests
exist.
* E-mail: tlane@uci.edu
PLoS Pathogens | www.plospathogens.org 1 July 2010 | Volume 6 | Issue 7 | e1000937Figure 1. Functional roles of chemokines in response to viral infection of the CNS. Potential roles of chemokines in attracting innate
immune cells (A) and lymphocytes (B) into the CNS during acute viral infection. The cartoons emphasize several key points derived from recent
studies focusing on experimental infection with neurotropic viruses. (A) Early (days 1–3) after viral infection, activated and/or virally infected
astrocytes, microglia, and endothelial cells secrete chemokines that serve to attract myeloid cells to the CNS. Among the earliest cells to respond to
viral infection, neutrophils are recruited into the CNS by virtue of CXCR2 responding to ligands expressed within the CNS (e.g., CXCL1). Monocytes are
also attracted into the CNS via the chemokine CCL5 and its receptor CCR5. Neutrophils and monocytes participate in the degradation of the blood–
brain barrier (BBB), in part through the release of the matrix metalloproteinase MMP-9, and therefore ensure successive infiltration of virus-specific
lymphocytes into the CNS. (B) During the acute stage of disease, astrocytes, microglia, neurons, and endothelial cells continue to secrete chemokines,
serving to attract activated T lymphocytes, NK cells, and monocytes into the CNS. CD8+ and CD4+ T lymphocytes bearing the receptor CXCR3 and/or
PLoS Pathogens | www.plospathogens.org 2 July 2010 | Volume 6 | Issue 7 | e1000937protective response, and we are just now learning how chemokines
are involved in attracting these cells to the CNS. Infection of mice
with neurotropic virus such as HSV-1 and JHMV results in the
rapid accumulation of neutrophils to the CNS [13,14]. Studies
using the JHMV model system have provided insight into the
functional relevance of neutrophil migration to the CNS, as these
cells are required to contribute to the permeabilization of the BBB
[14]. During JHMV infection, astrocyte- and endothelial-derived
expression of ELR+ (glutamic acid-leucine-arginine) CXC che-
mokines, including CXCL1, attracts CXCR2-reactive neutrophils
to the CNS [14]. Neutralization of this signaling axis specifically
abrogates neutrophil infiltration, thereby preventing BBB degra-
dation and the ensuing entry of protective JHMV-specific T
lymphocytes [14]. In the absence of CXCR2 signaling, JHMV-
infected mice experience higher viral loads and quickly succumb
to infection, indicating that neutrophil targeting of the CNS is
critical in host defense [14]. Conversely, McGavern and colleagues
have suggested that during acute LCMV infection (Armstrong
strain), cytotoxic T lymphocyte (CTL)-mediated chemokine gene
expression contributes to fatal meningoencephalitis, in part, by
attracting neutrophils and monocytes into the CNS, and this is
associated with fatal vascular permeability and seizures, thus
highlighting a detrimental role for neutrophils in response to viral
infection [15]. In addition to enhancing the permeabilization of
the BBB by recruiting neutrophils and monocytes, chemokines can
also function as gatekeepers regulating leukocyte penetration into
the parenchyma. Following WNV infection of the CNS, CXCL12
retains antigen-sensitized lymphocytes within the perivascular
space. Antagonism of CXCR4, the receptor for CXCL12,
enhances T lymphocyte entry into the CNS parenchyma, and
this correlates with reduced WNV burden, enhanced survival, and
limited neuropathology [16]. Thus, expression of chemokines early
in response to infection with neurotropic viruses aids in effective
host defense by promoting vascular permeability and regulating
parenchymal lymphocyte infiltration (Figure 1A). However, it
should be emphasized that the consequences of BBB degradation
can vary from efficient viral clearance to fatal encephalitis and
seizures, depending upon the virus and the route of infection.
Chemokines and Neuroprotection during Viral
Infection
Although early signaling events are clearly important for host
defense during viral infection, the infiltration and anti-viral activity
of T lymphocytes are requisite for viral clearance and survival.
CXCL10, which is prominently expressed within the CNS during
many viral infections [1,17], functions to attract activated T
lymphocytes bearing the receptor CXCR3. Neutralization or
genetic silencing of CXCL10 following infection with HSV,
JHMV, and WNV dramatically reduces T cell trafficking into the
CNS, thus preventing efficient viral control and often resulting in
poor resolution [6,18,19]. In addition to attracting T lymphocytes,
the CXCR3 ligands CXCL10 and CXCL9 also attract natural
killer (NK) cells during JHMV infection [20,21]; however, their
role in viral clearance remains unclear. The macrophage and T
lymphocyte chemokine CCL5, or one of its receptors, CCR5, also
promotes leukocyte trafficking into the CNS and subsequent viral
control during JHMV infection and WNV-induced encephalitis
[22,23]. The clinical relevance of this observation was revealed
when homozygosity for the defective human CCR5 allele
(CCR5D32) was associated with an increased risk for symptomatic
WNV infection [24]. Collectively, these data demonstrated that
chemokine expression during viral infection promotes the
generation and infiltration of immune effector cells necessary for
quelling viral replication (Figure 1B).
Chemokines and Neuropathology following Viral
Infection
A potential consequence of chemokine secretion and the
subsequent accumulation of leukocytes within the CNS, while
important for viral control in many instances, is the development
of neuropathology. For example, the fatal meningoencephalitis
induced by LCMV infection is mediated by infiltration of virus-
specific CTLs that promote subsequent myeloid cell and leukocyte
entry [15,25]. During infection with LCMV (Traub), genetic
silencing of CXCL10 or its receptor CXCR3 reduces the
infiltration of CD8+ T cells, conferring either partial or near
complete protection from immunopathology and death [26,27].
However, CXCL10 remains dispensable for T cell infiltration or
the development of fatal inflammation during infection with
LCMV (Armstrong) [28], further highlighting underlying differences
in viral strains and chemokine utilization with regards to disease
outcome. During JHMV infection, sustained CXCL10 and CCL5
expression leads to continuing immune cell infiltration that
manifests an immune-mediated demyelinating disease. Neutrali-
zation of either chemokine during persistent JHMV infection
abrogates the immune infiltration and greatly reduces both disease
severity and demyelination [29,30]. In addition to attracting
inflammatory cells that contribute to neuropathology, CXCL10,
which is chronically expressed within the brains of patients
suffering from HIV-associated neurological disorders, can directly
induce neuronal cell death [5]. In addition, proteolytically cleaved
CXCL12, which is also detectable within the brains of HIV-1-
infected patients, is capable of inducing neurotoxicity and
apoptosis [31]. Although beyond the scope of this review,
extensive work has focused upon the direct and indirect roles of
the chemokine receptors CXCR4 and CCR5 (and their associated
ligands) in contributing to HIV-associated dementia (reviewed in
[32,33]). Therefore, chemokines are critical mediators of neuro-
pathology during viral infections of the CNS, either by attracting
pathogenic inflammatory cells or directly mediating neurotoxicity
and cell death.
Conclusions
From this brief review, it is evident that the biological roles of
chemokines in host defense and/or disease in response to viral
infection of the CNS are constantly evolving. An emerging picture
has developed that indicates that chemokines and their receptors
are intimately involved in generation of effective host responses to
viral infections within the CNS. Paradoxically, chemokine
expression has also been associated with neuropathology. Thus,
chemokines and/or chemokine receptors are potentially relevant
targets for treating various viral-induced neuropathies by damp-
ening specific biological functions associated with disease. Recent
evidence has emerged implicating chemokines, specifically
CCR5 are attracted by the chemokines CXCL10 and CCL5, respectively, and mediate viral control through direct cytolytic activity and/or cytokine
secretion. CXCL12, which signals through CXCR4, may, however, sequester T lymphocytes within the perivascular space and regulate penetration of
the parenchyma, thus inhibiting efficient viral clearance.
doi:10.1371/journal.ppat.1000937.g001
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[34]; thus, chemokines produced during viral infections may
influence neural precursor cell function and therefore influence
recovery and repair. We can only look forward to future research
that will undoubtedly uncover new and exciting roles for the
chemokines in host defense, disease, and recovery within the
context of the virally infected CNS.
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